WASHINGTON, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)ADVANCED MEDICAL TECHNOLOGY ASSOCIATION, founded in 1974, is a mid-sized nonprofit that reported $48.6M in total revenue in fiscal year 2023.
ADVAMED ADVOCATES ON A GLOBAL BASIS FOR THE HIGHEST ETHICAL STANDARDS, TIMELY PATIENT ACCESS TO SAFE AND EFFECTIVE MEDICAL TECHNOLOGIES, AND ECONOMIC POLICIES THAT REWARD VALUE CREATION.
ADVAMED'S GOVERNMENT AFFAIRS FUNCTION REPRESENTS THE INDUSTRY BEFORE STATE AND FEDERAL POLICYMAKERS, IN GOVERNOR'S OFFICES, STATE LEGISLATURES, THE UNITED STATES CONGRESS, AND RELEVANT FEDERAL...
ADVAMED'S GOVERNMENT AFFAIRS FUNCTION REPRESENTS THE INDUSTRY BEFORE STATE AND FEDERAL POLICYMAKERS, IN GOVERNOR'S OFFICES, STATE LEGISLATURES, THE UNITED STATES CONGRESS, AND RELEVANT FEDERAL AGENCIES. ADVAMED'S ADVOCACY STAFF AND OUTSIDE CONSULTANTS PROVIDE INFORMATION ON POLITICAL AND POLICY DEVELOPMENTS, AND PURSUE THE INDUSTRY'S AGENDA FOR A LEGAL, REGULATORY AND ECONOMIC ENVIRONMENT THAT ADVANCES HEALTH CARE BY ASSURING PATIENT ACCESS TO THE BENEFITS OF MEDICAL TECHNOLOGY.
TAKING MEMBER COMPANY FEEDBACK FROM WORKING GROUPS AND COMMITTEES, ADVAMED STAFF PROVIDE CRITICAL INPUT TO REGULATORY AGENCIES LIKE FDA AND CMS ON REGULATIONS AND RULES THAT IMPACT THE ABILITY FOR...
TAKING MEMBER COMPANY FEEDBACK FROM WORKING GROUPS AND COMMITTEES, ADVAMED STAFF PROVIDE CRITICAL INPUT TO REGULATORY AGENCIES LIKE FDA AND CMS ON REGULATIONS AND RULES THAT IMPACT THE ABILITY FOR PATIENTS TO RECEIVE TIMELY ACCESS TO LIFE CHANGING DEVICES PRODUCED BY ADVAMED MEMBERS.
OUR CONSULTANTS IN JAPAN, CHINA, AND OTHER OVERSEAS MARKETS REPRESENT ADVAMED IN RAPIDLY EXPANDING OVERSEAS MARKETS AND ATTEND MEETINGS WITH GOVERNMENT OFFICIALS AND INDUSTRY COMMITTEE MEETINGS...
OUR CONSULTANTS IN JAPAN, CHINA, AND OTHER OVERSEAS MARKETS REPRESENT ADVAMED IN RAPIDLY EXPANDING OVERSEAS MARKETS AND ATTEND MEETINGS WITH GOVERNMENT OFFICIALS AND INDUSTRY COMMITTEE MEETINGS. THESE CONSULTANTS PROVIDE REAL-TIME INFORMATION AND AN INDUSTRY VOICE IN OVERSEAS MARKETS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $48,578,997 | $47,870,561 | +0.0% |
| Expenses | $48,608,902 | $44,643,330 | +0.1% |
| Net Income | $-29,905 | $3,227,231 | -1.0% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| PETER ARDUINI | TREAS. (UNTIL 12/23), CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| MICHAEL MINOGUE | CHARIPERSON (UNTIL 03/23) | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| GEOFF MARTHA | TREASURER (AS OF 12/2023) | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| ASHLEY MCEVOY | DIR. (THRU 3/23), CHAIR (3/23-10/23) | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| THOMAS MCGUINNESS | DIRECTOR (UNTIL 11/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL MUSSALLEM | DIRECTOR (UNTIL 03/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| NACHO ABIA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ANTOINETTE GAWIN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BRADY SHIRLEY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BRIAN MILLER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BRYAN HANSON | DIRECTOR (UNTIL (08/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| CARLTON ST BERNARD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CHRISTOPHER SIMON | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DAMIEN MCDONALD | DIRECTOR (UNTIL 04/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| DAN CARESTIO | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DAVID ENDICOTT | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DAVID PACITTI | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DEEPAK NATH | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DONALD BOBO | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ERIC ZACHARIAS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| GEORGE MALIEKEL | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| GIUSEPPE ACCOGLI | DIRECTOR (UNTIL 01/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| HOLLY SHEFFIELD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| IVAN TORNOS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JAMES CLEMMER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JAN DE WITTE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JEAN-CLAUDE DUBACHER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JEFF DILULLO | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JEFF MIRVISS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JIM HOLLINGSHEAD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOAKIM WEIDEMANIS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JONATHAN RENNERT | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOSE ALMEIDA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOSEPH VIRGILIO | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOSEPH WOODY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JULIANA ELSTAD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KEN REALI | DIRECTOR (UNTIL 04/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| KEVIN LOBO | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LIAM KELLY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LISA EARNHARDT | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LISHAN AKLOG | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MANU VARMA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MARTHA SHADAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MATTHEW SAUSE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MAUREEN MULVIHILL | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL FARRELL | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| NADIM YARED | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| NORMAN SCHWARTZ | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RICHARD FABIAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| STEPHEN MACMILLAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| STEPHEN MASON | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SVEN SCHMIDT | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| THIERRY BERNARD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| THOMAS KAPFER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| THOMAS POLEN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TIM SCHMID | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TIMOTHY DUGAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TODD POPE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TOM EISIMINGER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TRACY MACNEAL | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| VENK VARADAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| VITOR ROCHA | DIRECTOR (UNTIL 02/2023) | 1.00 |
Director
|
$0 | $0 | $0 |
| SCOTT WHITAKER | CHIEF EXECUTIVE OFFICER | 40.00 |
Officer
|
$2,363,876 | $76,306 | $2,440,182 |
| CHRISTOPHER L WHITE | GENERAL COUNSEL & CHIEF POLICY OFF. | 40.00 |
Officer
|
$1,005,180 | $72,611 | $1,077,791 |
| JENNIFER BREAREY | CHIEF FINANCIAL & OPERATING OFFICER | 40.00 |
Officer
|
$624,653 | $72,611 | $697,264 |
| GREG CRIST | CHIEF ADVOCACY OFF. & HEAD EXT. AFFAIRS | 40.00 |
Key Emp
|
$684,666 | $72,609 | $757,275 |
| RAY BRISCUSO | EVP, CONFERENCES & EVENTS | 40.00 |
Key Emp
|
$523,226 | $72,609 | $595,835 |
| ASHLEY MILLER | EVP, GLOBAL STRATEGY & ANALYSIS | 40.00 |
Key Emp
|
$404,704 | $34,651 | $439,355 |
| JANET TRUNZO | EVP, TECH AND REGULATORY AFFAIRS | 40.00 |
Highest
|
$670,125 | $49,973 | $720,098 |
| ZACHARY ROTHSTEIN | EXECUTIVE DIRECTOR, ADVAMEDDX | 40.00 |
Highest
|
$444,314 | $72,551 | $516,865 |
| KIMBERLY ZIMMERMAN | SVP, HEAD OF FEDERAL GOV'T AFFAIRS | 40.00 |
Highest
|
$485,045 | $72,609 | $557,654 |
| DECHANE DORSEY | EXECUTIVE DIRECTOR, ADVAMED ACCEL | 40.00 |
Highest
|
$430,330 | $50,303 | $480,633 |
| ANDREW STEINER | SVP, BUSINESS DEVELOPMENT | 40.00 |
Highest
|
$427,880 | $56,491 | $484,371 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $48,578,997 | $48,608,902 | $42,346,557 | $-29,905 |
| 2022 | $47,870,561 | $44,643,330 | $41,806,177 | $3,227,231 |
| 2021 | $41,851,836 | $38,460,389 | $28,228,671 | $3,391,447 |
| 2020 | $41,825,177 | $40,166,786 | $22,107,131 | $1,658,391 |
| 2019 | $43,356,283 | $42,338,249 | $20,575,198 | $1,018,034 |
| 2018 | $41,344,473 | $41,162,817 | $18,080,233 | $181,656 |
Compare ADVANCED MEDICAL TECHNOLOGY ASSOCIATION with other nonprofits in District of Columbia and across the country.